Oriola (ORIOLA.HE) Stock Analysis & AI Equity Report
Oriola (ORIOLA.HE) overview
Oriola (ORIOLA.HE) stock analysis and AI equity research. For the latest completed financial year, 2025, Oriola reported revenue of EUR 1,906m and operating profit of EUR 1.4m; the year-end share price was 1.15 EUR and market capitalisation was EUR 212m. A completed Oriola AI equity report is available from 1 June 2026; you can buy the ready PDF or generate a fresh report with the latest available data.
Key metrics & valuation multiples
About Oriola
Oriola Oyj is a Nordic healthcare company focused on pharmaceutical distribution, wholesale services and pharmacy retail. It supplies medicines, health and wellbeing products, and related services to pharmacies, consumers and healthcare providers in Finland and Sweden. The company also serves hospitals and other professional customers through its healthcare trade and distribution operations.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Oriola Oyj and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Buy the ready Oriola report
A completed Oriola AI equity report is available from 1 June 2026. Buy the ready PDF now, or generate a new report below if you want a fresh run with the latest available data.
Or generate new Oriola report
Generate a new Oriola report with the latest available data for a refreshed company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.